The fiscal incentives for reducing HAIs are significant. A 2015 study found Clostridium difficile infections increased hospital costs by 40 percent per instance of infection and also increased the patient’s risk for readmission. Under the ACA’s Hospital-Acquired Condition Reduction Program, Medicare reduced payments for 758 hospitals with high rates of hospital-acquired conditions for fiscal year 2016.
To facilitate HAI reduction, healthcare organizations must look at the problem from all angles, including care bundles, patient acuity, hand hygiene compliance, antibiotic stewardship, fecal waste management and environmental disinfection.
During a September 15 webinar sponsored by Sealed Air Diversey Care, Jim Gauthier, senior clinical advisor, infection prevention, with Sealed Air Diversey Care, will lead a discussion aimed at identifying the multiple factors that can influence HAI risk, evaluating if current practices are comprehensive enough to address these risks and ultimately creating a successful formula to improve compliance and reduce HAIs.
To learn more and register for the webinar, click here.
More articles on infection control:
Early antibiotic exposure linked to food allergies in children
Nearly 60 suspected cases of mumps in Arkansas outbreak
Translational Genomics Research Institute validates new HAI screening tool
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
